Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

China Medical Device Market

ID: MRFR/MED/42598-HCR
200 Pages
Rahul Gotadki
Last Updated: April 06, 2026

China Medical Device Market Research Report: Size, Share, Trend Analysis By Device Type Outlook (Drug Delivery System, Diagnostic Device, Invasive Device, Respiratory Therapeutic Device, Electronic Medical Device, Others), By Applications Outlook (Cardiovascular Diseases, Diagnostic Imaging, Orthopedics, Oncology, Ophthalmology, General Surgery, Respiratory, Dental, Ear, Nose, and Throat (ENT), Neurology, Nephrology Urology, Others) and By End Users Outlook (Hospitals Clinics, Ambulatory Surgical Centers, Homecare Settings, Others) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

China Medical Device Market  Infographic
Purchase Options
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Application (USD Billion) | |
      1. 4.1.1 Diagnostic Devices | |
      2. 4.1.2 Therapeutic Devices | |
      3. 4.1.3 Monitoring Devices | |
      4. 4.1.4 Surgical Instruments | |
      5. 4.1.5 Dental Devices |
    2. 4.2 Healthcare, BY End Use (USD Billion) | |
      1. 4.2.1 Hospitals | |
      2. 4.2.2 Clinics | |
      3. 4.2.3 Home Care | |
      4. 4.2.4 Ambulatory Surgical Centers | |
      5. 4.2.5 Diagnostic Laboratories |
    3. 4.3 Healthcare, BY Product Type (USD Billion) | |
      1. 4.3.1 Imaging Equipment | |
      2. 4.3.2 Surgical Instruments | |
      3. 4.3.3 Patient Monitoring Equipment | |
      4. 4.3.4 In Vitro Diagnostic Devices | |
      5. 4.3.5 Dental Equipment 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Medtronic (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Siemens Healthineers (DE) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Philips (NL) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 GE Healthcare (US) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Johnson & Johnson (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Becton Dickinson (US) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Stryker (US) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Abbott Laboratories (US) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies | |
      9. 5.2.9 Fujifilm (JP) | | |
        1. 5.2.9.1 Financial Overview | | |
        2. 5.2.9.2 Products Offered | | |
        3. 5.2.9.3 Key Developments | | |
        4. 5.2.9.4 SWOT Analysis | | |
        5. 5.2.9.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 CHINA MARKET ANALYSIS BY APPLICATION |
    6. 6.3 CHINA MARKET ANALYSIS BY END USE |
    7. 6.4 CHINA MARKET ANALYSIS BY PRODUCT TYPE |
    8. 6.5 KEY BUYING CRITERIA OF HEALTHCARE |
    9. 6.6 RESEARCH PROCESS OF MRFR |
    10. 6.7 DRO ANALYSIS OF HEALTHCARE |
    11. 6.8 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    12. 6.9 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    13. 6.10 SUPPLY / VALUE CHAIN: HEALTHCARE |
    14. 6.11 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
    15. 6.12 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion) |
    16. 6.13 HEALTHCARE, BY END USE, 2024 (% SHARE) |
    17. 6.14 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion) |
    18. 6.15 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE) |
    19. 6.16 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion) |
    20. 6.17 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    21. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    22. 7.2 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY APPLICATION, 2026-2035 (USD Billion) | |
      2. 7.2.2 BY END USE, 2026-2035 (USD Billion) | |
      3. 7.2.3 BY PRODUCT TYPE, 2026-2035 (USD Billion) |
    23. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.3.1 |
    24. 7.4 ACQUISITION/PARTNERSHIP | |

China Healthcare Market Segmentation

Healthcare By Application (USD Billion, 2026-2035)

  • Diagnostic Devices
  • Therapeutic Devices
  • Monitoring Devices
  • Surgical Instruments
  • Dental Devices

Healthcare By End Use (USD Billion, 2026-2035)

  • Hospitals
  • Clinics
  • Home Care
  • Ambulatory Surgical Centers
  • Diagnostic Laboratories

Healthcare By Product Type (USD Billion, 2026-2035)

  • Imaging Equipment
  • Surgical Instruments
  • Patient Monitoring Equipment
  • In Vitro Diagnostic Devices
  • Dental Equipment

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions